Science

Nanoscale tech tracks proteins inside living neurons to guide Alzheimer's and Parkinson's drug discovery

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 20/10/2026, 01:10:24 UTC.

Briefings

A University of Queensland technology enables single-molecule observation of disease proteins inside living neurons, accelerating drug discovery for Alzheimer's and Parkinson's. The NASTIC platform, spun out by Accretion Bio, allows researchers to track real-time biological processes across space and time at the single-molecule level for the first time.

Key points

• The NASTIC platform enables single-molecule observation of disease proteins inside living neurons.
• The platform is a spinout of The University of Queensland and is operated by Accretion Bio.

Context

This technology allows scientists to observe how disease-related proteins behave inside living neurons, advancing early drug discovery for neurodegenerative diseases.

Limitations

Evidence is limited to a single article from October 2026. Specific dates, numbers, or named researchers are not provided. The article describes the platform's capabilities but does not detail specific experimental results, data sets, or outcomes.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 20/10/2026, 01:15:32 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeibwq3wglrlqvgrnuqrl62fq65fjteagmam7zakcobstlbyizyzv7q